JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SUGRUE, M. F.
Right arrow Articles by SHORE, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SUGRUE, M. F.
Right arrow Articles by SHORE, P. A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 177, Issue 2, 389-397, 1971
Copyright © 1971 by American Society for Pharmacology and Experimental Therapeutics


FURTHER EVIDENCE FOR A SODIUM-DEPENDENT, OPTICALLY SPECIFIC AND RESERPINE-SENSITIVE AMINE CARRIER MECHANISM AT THE ADRENERGIC NEURON

M. F. SUGRUE 1 and P. A. SHORE 1

1 Department of Pharmacology, University of Texas Southwestern Medical School, Dallas, Texas

The uptake of the two erythro and two threo isomers of metaraminol (MA) by rabbit heart slices is a Na+-dependent process. Of the four stereoisomers, only the uptake of (—)-erythro-MA (l-MA) in low [Na+] is markedly decreased by reserpine. The effect of reserpine on l-MA uptake at low [Na+] is relatively short-lived as compared with the effect of the drug on endogenous catecholamine levels. Thus, 48 hours after reserpine, l-MA uptake in low [Na+] was essentially unaltered. Tetrabenazine also potentiated the inhibitory effect of low [Na+] on l-MA uptake, and competitive studies suggest that reserpine and tetrabenazine share the same site of action on the optically specific amine carrier mechanism. Guanethidine, under conditions which greatly inhibited the intraneuronal granular storage mechanism, had no effect on l-MA uptake at low [Na+]. Hence, the ability to inactivate the optically specific reserpine-sensitive amine carrier system is a specific effect not possessed by all drugs which decrease endogenous catecholamine levels. Bretylium and debrisoquin, at doses evoking adrenergic neuron blockade, also had no effect on l-MA uptake at low [Na+]. It is suggested that the Na+-dependent, optically specific and reserpine-sensitive amine carrier mechanism may constitute a component of the functional or "available" norepinephrine pool.

Submitted on October 16, 1970
Accepted on February 2, 1971







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics.